TEL. 03-3353-8111
〒162-8666 8-1, Kawada-cho, Shinjuku-ku, Tokyo
Rheumatology and Gout Center was established in 1982 as a medical institution specializing in rheumatic diseases, and in May 2018, it was newly established as a department of Collagen Disease and Rheumatology in the School of Medicine.
Following Prof. Kiyomasa Omori (1st), Prof. Sadao Kashiwazaki (2nd), Prof. Naoyuki Kamatani (3rd), and Hisashi Yamanaka (4th), Masayoshi Harigai has been appointed as the 5th Professor and Head of the Core Division since 2018.
In our course, we advocate the three pillars of our department are
①Safe and high quality medical care,
②Attractive pre- and post-graduate education, and
③Cutting-edge research and aim to produce outstanding results by integrating these.
Rheumatic diseases are multi-organ diseases, and treatment continues throughout life. Therefore, clinical training in the Department of Collagen and Rheumatology is a unique learning opportunity for medical students to learn to examine the whole body and to provide holistic medical care that is sympathetic and attentive to patients. We place emphasis on hands-on clinical practice, and makes various efforts to enhance practical skills as a physician. One of these is the practice of interviewing, examining, and charting patients in an outpatient setting. We provide clinical practice that is not limited to the acquisition of knowledge, but also focuses on clinical reasoning and consideration of pathological conditions.
To become a good collagen disease/rheumatology specialist, it is important to gain clinical experience under several excellent supervisors, learn how to make a logical diagnosis and select a treatment plan based on EBM, and develop a method and habit of lifelong learning on your own. The clinical training at the Department of Collagen and Rheumatology of Tokyo Women's Medical University fulfills exactly these requirements, so you can efficiently learn the knowledge and experience necessary to become a medical specialist by training here. Internal medicine specialists can be obtained in the sixth year after graduation, and collagen disease and rheumatology specialists can be obtained in the seventh year after graduation at the earliest.
Opportunities for learning specialized knowledge include weekly medical director rounds, ward director rounds, internal medicine case review meetings, online educational seminars for majors conducted by staff in our department, and external lectures in which our staff serve as speakers. In addition, we regularly hold a rheumatology seminar named IOR Rheumatology Seminar every year, which is attended by many young physicians from outside medical institutions.
Our department conducts cutting-edge basic medical research and clinical medical research that takes advantage of economies of scale. We are able to experience the significance of clarifying questions at the bedside through basic medical research, returning the results to the bedside, and further developing them into clinical research. Our staff members are also principal investigators and co-investigators of many public research projects (e.g., funded by the Ministry of Health, Labor and Welfare, AMED, etc.) and are deeply involved in multicenter clinical medical research on rheumatic diseases and the development of medical guidelines, making our department an ideal environment for those who want to be involved in clinical medical research.
1. Basic medical research
- Research on molecular mechanisms of pathogenesis of rheumatoid arthritis and methods of prevention
- Research on the molecular pathogenesis of systemic lupus erythematosus
- Elucidation of etiology and pathogenesis of ANCA-associated vasculitis by genetic analysis
- Research on molecular pathogenesis of systemic scleroderma
2. Clinical medical research
- Large cohort study of rheumatoid arthritis (IORRA)
- Health economics research on rheumatoid arthritis
- Research on pathogenesis, diagnosis and treatment of pediatric rheumatic diseases
- Research on diagnosis and treatment of systemic lupus erythematosus
- Clinical epidemiology research and investigator-initiated clinical trials for ANCA-associated vasculitis
- Research on diagnosis and treatment of scleroderma
- Clinical and epidemiological studies on spondyloarthritis
- Pharmacoepidemiological research of rheumatic diseases by big data analysis
Masayoshi Harigai
Yasushi Kawaguchi
Eiichi Tanaka
Takako Miyamae
Yasuhiro Katsumata
Mutsuto Tateishi
Yuko Okamoto
Katsunori Ikari
Tomoaki Higuchi
Many molecular targeted therapeutics are used in the treatment of rheumatoid arthritis and collagen diseases, and excellent therapeutic results have been published. However, the etiology of these diseases is still in the process of being elucidated, and many research issues remain to be addressed. In addition, although clinical trials have shown excellent therapeutic results, knowledge on how to improve efficacy and safety in daily practice and health economic considerations are not necessarily sufficient.
In the graduate school of our field, we take advantage of the clinical classroom to bring questions that arise at the bedside back to the laboratory and use them as an opportunity to launch research questions. Then, basic medical research is analyzed at the cellular, molecular, and genetic levels at the laboratory bench in basic medical research, and clinical medical research is conducted by building databases and performing epidemiological and statistical analyses to find answers to research questions.
If you are considering our graduate school, please refer to the related links.
Research Achievements Database
〒162-8666
8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL +81-3-3353-8111